Showing 183 results

Filters Content type: News, Editors' picks Topic: Weight gain & lipodystrophy

Many people put on a little weight after starting antiretroviral treatment, linked to a general improvement in health. However, some specific anti-HIV drugs may affect the structure of body fat and cause more weight gain than others. The mechanisms are different to lipodystrophy, which was a side effect of anti-HIV drugs which are now rarely used.

HIV treatment

Top 10 HIV Clinical Developments of 2019

Editor's pick
TheBodyPro
27 November 2019
Weight gain & lipodystrophy

Dolutegravir and raltegravir cause changes to fat cells

News
11 November 2019
Side effects

Weight gain after switching to integrase inhibitor treatment is small in Dutch and Swiss cohorts

News
11 November 2019
Side effects

ADVANCE study shows high frequency of major weight gain in women receiving dolutegravir with TAF

News
8 November 2019
Side effects

Weight gain on HIV treatment: drug combinations, not single drugs, need to be focus of quest for cause

News
8 November 2019
Starting treatment

Weight gain on HIV treatment: more common with newer drugs, low CD4 counts

News
31 October 2019
Cardiovascular disease

Combining statins and physical exercise has big benefits for people with HIV and high lipids

News
28 August 2019
Side effects

Dolutegravir leads to weight gain in two African studies

News
23 July 2019
Side effects

Weight gain with new antiretrovirals: It's complicated

Editor's pick
Spotlight
15 April 2019
Weight gain & lipodystrophy

The impact of older antiretrovirals on fat redistribution and cardiovascular risk factors may be irreversible

News
21 March 2019
Side effects

Integrase inhibitor treatment leads to greater weight gain

News
7 March 2019
Side effects

Do integrase inhibitors raise the risk of obesity?

News
10 January 2019
Diabetes

High prevalence of diabetes and pre-diabetes in people at London HIV clinics

News
30 November 2018
Cardiovascular disease

Treatment with modern antiretrovirals doesn't increase the risk of hypertension

News
14 August 2018
PrEP science

PrEP does not raise lipids or alter body fat, safety study finds

News
15 February 2018
Diabetes

Diabetes in people with HIV over 50 overwhelmingly linked to old antiretrovirals, not age or body weight

News
3 January 2018
Changing treatment

HIV Regimen Switch May Contribute to Weight Gain

Editor's pick
Monthly Prescribing Reference
9 October 2017
Side effects

Lipids improved by switching from ritonavir to cobicistat as a booster for darunavir

News
6 September 2017
Hepatitis C symptoms & diagnosis

Switching from efavirenz to raltegravir leads to significant improvements in fatty liver disease in people with HIV

News
17 August 2017
Hepatitis & HIV

Non-alcoholic fatty liver disease common in people living with HIV – metabolic disorders are key risk factors

News
12 July 2017
Side effects

High prevalence of low testosterone among younger and middle-aged ART-treated men in France

News
24 January 2017
Weight gain & lipodystrophy

The benefit of treatment has outweighed the clinical impact of lipodystrophy, conference hears

News
26 October 2016
Weight gain & lipodystrophy

Two Experts Discuss HIV, Abdominal Fat and Body Shape Changes

Editor's pick
The Body
24 August 2016
Ageing & HIV

Middle-aged people living with HIV have an increased risk of frailty

News
13 January 2016